Once a fierce contender for BMW, the Acura TLX ends production. Explore the history and performance of the sedan that almost ...

Telix Pharmaceuticals' strong sales, diverse pipeline, and theranostics promise support a Buy rating, despite SEC concerns.

In Cars.com’s most popular news story of the past week, we break down the 2026 Toyota Corolla. See the full list of stories here.

After 11 model years on the market, Acura is discontinuing the TLX. Here are some other vehicles you should consider as a ...

Acura is officially ending production of the TLX sedan this month, marking the end of a nameplate that has carried the torch ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for ...

Here are a couple of ASX 200 shares that analysts are tipping to rise strongly from current levels. Here's what you need to ...

The Acura TLX is officially dead.After three decades on the road and over 1 million cars sold, Acura will end production of ...

MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the ...

The Acura TLX, once a mainstay sedan for the Japanese luxury brand, is coming to the end of its production run. Due to ...

Yet another midsize sedan bites the dust as Acura will end production of the TLX at the end of this month, leaving the ...

Cadillac CT5 sales grew nine percent to 4,187 units in Q2 2025, placing BMW, Mercedes-Benz, and Lexus, but ahead of Audi, ...